Introduction
============

With the advancement of the clinical stages of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and interstitial pneumonia (IP), dyspnea on effort intensifies and patient activity of daily life is deteriorated. The onset of secondary pulmonary arterial hypertension (PAH), in addition to respiratory insufficiency, is thought to aggravate symptoms.^[@B1]--[@B3]^ Therefore, respiratory and cardiovascular physicians have been increasingly focused on the evaluation of PAH in the management of the patients with respiratory diseases.

PAH, characterized by peripheral blood vessel contraction and vascular remodeling, is a pulmonary vascular disease that leads to a gradual increase in pulmonary vascular resistance. The current standard diagnostic technique that is routinely employed to evaluate hemodynamics of PAH patients is right heart catheterization (RHC).^[@B4]--[@B6]^ Due to the relative invasiveness of RHC, alternative non-invasive methods have been sought for the analysis of hemodynamics.^[@B7]--[@B13]^ For this purpose, hemodynamic information derived from flowmetry with two-dimensional (2D) phase contrast (PC) magnetic resonance (MR) technique such as acceleration time (AT)^[@B7]^ or peak velocity (PV)^[@B7],[@B8]^ have been tested for potential indicators of PAH ([Fig. 1](#F1){ref-type="fig"}). However, the 2DFT method sometimes suffers from inconsistent data depending on the prescribed measurement planes in the pulmonary arteries. Most profound weakness of the 2D PC cine MR is that the measurement planes cannot be optimized during the examination. With phase-resolved 3D PC images, more robust, quantitative, visual recognitions of the flow dynamics of the whole pulmonary arteries are allowed. Once data are acquired, retrospective measurements of hemodynamic parameters are available.

In this study, we have investigated whether hemodynamic parameters of the 3D MR flowmetry such as wall shear stress (WSS) ^[@B14]--[@B17]^ or oscillatory shear index (OSI) can reflect PAH.

Materials and Methods
=====================

Institutional Review Board (IRB) approved the prospective study which was conducted between April 2011 and December 2013.

Patients
--------

Seventeen consecutive patients with respiratory diseases who were suspected of having PAH by routine cardiac ultrasonography were enrolled in the study. Written informed consent was obtained from all patients. All patients underwent RHC and 3D cine PC MR. The subjects comprised 14 males and 3 females with mean age of 75.2 years. Based on the RHC data, 5 patients were diagnosed as PAH (3 males, 2 females, median age of 77 years) and 12 patients were diagnosed as non-PAH (11 males, 1 females, median age of 74.5 years). Patient demographics are shown in [Table 1](#T1){ref-type="table"}.

MR system and imaging parameters
--------------------------------

All patients underwent 3D cine PC MR on a 3T MR system (Signa HDxt, General Electric Healthcare, Waukesha, Wisconsin, USA) with a 32-channel cardiac phased array coil.

With 3D cine PC MR, 3D volume data of magnitude images and phase images with velocity components over time were obtained.^[@B15]--[@B17]^ Oblique-axial sections covering the whole pulmonary artery trunk and right and left main pulmonary arteries were prescribed. Electrocardiogram (ECG) gating and respiratory compensation were also combined.^[@B17]^ The parameters for 3D cine PC MR were: repetition time (TR)/echo time (TE)/flip angle (FA)/number of excitations (NEXs) of 5.6/2.8/9/1; field of view (FOV) of 350 × 260 × 60 mm; matrix of 256 × 224 × 30 \[256 × 224 × 60 with zero filled interpolation (ZIP)\]; voxel size of 1.3 × 1.2 × 2 mm^3^ (1.3 × 1.3 × 1 mm^3^ with ZIP); receiver bandwidth of 62.5 kHz/FOV; 20 phases/cardiac cycle; velocity encoding (VENC) of 150 cm/s; view per segment (VPS) of 4; in plane reduction factor for autocalibrating reconstruction for Cartesian imaging (ARC) of 2. Scan time was 8.2 min on average. To avoid an aliasing in velocimetry, relatively high VENC of 150 cm/s was adopted.

Data processing
---------------

Magnitude images of 3D cine PC MR and phase images of each three orthogonal directions were transferred to a personal computer (2.1-GHz Intel Core i3 CPU, Microsoft Windows ^[@B7]^ in DICOM format. MR image data were post-processed with flow analysis software (Flova, R'Tech Co. Ltd., Hamamatsu, Shizuoka).

Pulmonary arterial boundary was segmented based on the intensities of both magnitude images and phase images obtained with 3D cine PC MR.^[@B18]^ Segmentation was done by region growing method, and then morphological boundary was determined by the marching cube method. Velocity data in each voxel included inside the vascular boundary were incorporated from phase images with resolution of 1.5 mm and a time-course 3D velocity field containing a time component was obtained.

Measurements of the conventional hemodynamic markers
----------------------------------------------------

Hemodynamic parameters AT and PV were analyzed on the cross section perpendicular to the pulmonary artery trunk 1 cm proximal to the bifurcation. Blood vessel section area (BVSA) was also measured at the same location. AT was defined as the time from the beginning of antegrade flow to the systolic flow peak.^[@B7]^ PV was defined as the peak speed of the systolic blood flow ([Fig. 1](#F1){ref-type="fig"}).

Measurements of WSS and OSI
---------------------------

WSS is a dynamic frictional force induced by blood flow along the surface of the vascular walls.^[@B19]--[@B21]^ OSI was defined as "fluctuation" of the WSSs of the vascular wall.^[@B22]^ Two independent operators (M.T. and K.M) with 9-year and 7-year experiences in flow analysis measured systolic WSS (sWSS), diastolic WSS (dWSS), and mean WSS (mWSS) by placing cylindrical ROI (width of 3 pixels and the mean size of the ROI was 208 pixels) surrounding the pulmonary artery trunk at 1 cm proximal to the bifurcation.

Streamline analysis
-------------------

Streamline images^[@B14],[@B15],[@B22],[@B23]^ within the pulmonary artery were delineated for each patient with the flow analysis software. Abnormal hemodynamic patterns such as vortex or helical flow patterns were blindly assessed by two independent observers (Y.T. and M.T.) with 9 years experience in flow analysis. The degree of abnormal flow patterns were rated in three grades as 0 (none, consistent laminar flow without any discernible vortex or helical flow): 1 (moderate, one abnormal flow pattern involving more than 1/3 area of the lumen of the pulmonary trunk): 2 (severe, more than two abnormal flow patterns involving more than 1/3 of the lumen of the pulmonary trunk). The rating was performed separately for systole and diastole. The abnormal flow patterns could be instantaneous or prolonged during the period of observations.

Statistics
----------

AT, PV, sWSS dWSS, mWSS, OSI, and BVSA obtained by MR were compared between non-PAH and PAH groups with non-parametric Mann-Whitney U test with Bonferroni's correction.

Regression analysis was performed to test whether PAP measured by RHC correlated with hemodynamic parameters AT, PV, sWSS, dWSS, mWSS, OSI, and BVSA. Intra and interoperator agreement concerning the measurements of sWSS, dWSS, mWSS, and OSI by two operators were also assessed by regression analysis as well as Bland-Altman analysis. The regressions were examined by Spearman's rank correlation coefficient. A *P* value less than 0.05 was considered statistically significant.

Streamlines of pulmonary arteries were compared between the PAH and non-PAH patients. Interobserver variabilities concerning the abnormal flow patterns within the pulmonary arteries were analyzed by kappa statistics. Kappa values below 0.2 were interpreted as poor, 0.21--0.40 as fair, 0.41--0.60 as moderate, 0.61--0.8 as good, and 0.81--1.0 as very good agreements.

Results
=======

The results of hemodynamic data obtained by 3D cine PC MR are compared between the PAH and non-PAH patients ([Figs. 2a--c](#F2){ref-type="fig"}, [3a--c](#F3){ref-type="fig"}; [Table 2](#T2){ref-type="table"}). sWSS, mWSS, OSI, and BVSA at the pulmonary artery trunk was significantly different between the PAH and non-PAH patients. sWSS (N/m^2^) and mWSS (N/m^2^) of PAH group were lower than those of non-PAH group; (0.594 ± 0.067 vs. 0.961 ± 0.590, *P* = 0.001) and (0.365 ± 0.035 vs. 0.489 ± 0.132, *P* = 0.027). OSI of PAH group was higher than that of non-PAH group; (0.214 ± 0.026 vs. 0.130 ± 0.046, *P* = 0.001). BVSA of PAH group was larger than that of non-PAH group; (1104.5 ± 62.1 vs. 684.1 ± 129.1, *P* = 0.009).

The results comparing between hemodynamic data obtained by 3D cine PC MR and PAP are shown in [Table 3](#T3){ref-type="table"}. OSI and BVSA had a significantly positive correlation with mPAP, sPAP, and dPAP. PV, sWSS, dWSS, and mWSS had a negative correlation with mPAP and sPAP. Particularly, sWSS (r = --0.638, *P* = 0.005) and mWSS (r = --0.643, *P* = 0.005) had an obvious negative correlation with mPAP above all.

The results comparing between hemodynamic data obtained by 3D cine PC MR and BVSA are shown in [Table 4](#T4){ref-type="table"}. WSS and OSI were related to the size of the cross-sectional area of the pulmonary trunk. sWSS (r = --0.488, *P* = 0.049) had a negative correlation with BVSA, and OSI on the other hand, had a positive correlation with BVSA (r = 0.574, *P* = 0.016).

There were acceptable to negligible variability between two observers concerning the appearances of the abnormal flow patterns with kappa values of 0.545 (moderate agreement) to 0.750 (substantial agreement). The assessments of the pulmonary streamlines performed by the two observers are shown in [Table 5](#T5){ref-type="table"}. Severe abnormal flow patterns (grade 2) were observed in 1 to 2 out of 5 PAH patients during systole and diastole, and none in non-PAH patients ([Figs. 2a](#F2){ref-type="fig"}, [3a](#F3){ref-type="fig"}). Mild abnormal flow patterns (grade 1) were observed in 2 to 3 during systole and 3 to 4 during diastole out of 5 PAH patients, and in 2 during systole and 9 to 10 during diastole out of 12 non-PAH patients.

The intraoperator coefficients for all parameters (sWSS, dWSS, mWSS and OSI) were good (0.897 to 0.973) while those of the interoperator were excellent (0.939 to 0.980) ([Table 6](#T6){ref-type="table"}). Bland-Altman plots were also within the acceptable ranges of the bias ([Fig. 4a--i](#F4){ref-type="fig"}).

Discussion
==========

Previously, limited hemodynamic parameters such as AT or PV have been reported to be indicators for PAH.^[@B7],[@B8]^ In this study, WSS and OSI were assessed as potential indicators of secondary PAH, and they better reflected the PAP than conventional markers such as AT or PV. WSS is an instantaneous measure of the velocity gradient near the arterial wall. OSI is a temporal change of WSS as a function of the cardiac phases. We deem both WSS and OSI are essential in analyzing the abnormalities of the flow dynamics, because low WSS at single time point alone cannot precisely indicate the temporal abnormalities of the flow dynamics.

When sWSS and mWSS were compared between PAH and non-PAH patients, they were also significantly lower in the PAH patients, and sWSS and mWSS showed inverse linear regression with sPAP and mPAP. As the causative factors, it was hypothesized that the systolic and mean flow velocity was decreased by helical or vortex flow due to the high PAP. In an analysis of pulmonary embolism patients, Sanz et al.^[@B7]^ have reported that the peak velocity and average velocity of the blood flow within the pulmonary arteries had moderate to high inverse correlations to mPAP. In a sub-group of PAH, there was a weak correlation between peak velocity and mPAP.^[@B7]^ In addition, our results showed that BVSA and PAP at the pulmonary artery trunk had a positive linear correlation. Increased BVSA in PAP reflects positive remodeling of the pulmonary artery. It was presumed that the dilatation of the flow path resulted in a loss of blood flow momentum, which caused vortex and helical flow within the dilated pulmonary arteries.^[@B10]^ It is also presumed that the increased pulmonary vascular resistance and decreased compliance of the pulmonary arterial wall prevent smooth antegrade laminar flow toward the lung. This may cause reflected wave from the downstream blood flow to the upstream. The collision of the antegrade and retrograde flow may cause vortex or helical flow instead of laminar. Observers in this study recognized a vortex or spiral flow patterns during systole on the streamline images in 4 out of 5 patients of PAH, which may be reflecting this phenomena.

It was also noteworthy that OSI was significantly lower in the non-PAH patients and significantly higher in the PAH patients. In addition, OSI had a positive linear correlation with PAP. OSI is a sensitive indicator of chronological fluctuations of the local WSS, and it was speculated that OSI was influenced by irregular flow, particularly regurgitation that is more common in the PAH patients.^[@B10]^

Related to the phenomenon stated above, previous reports suggested that nitric oxide (NO) production is decreased in the endothelial cells that cover the pulmonary arteries of the PAH patient, and the dysfunction of endothelial cells have been reported to be a factor for peripheral pulmonary arterial vasoconstrictions and further progress of PAH.^[@B24]--[@B26]^ As a mechanoreceptor, endothelial cells are markedly sensitive to the changes of the WSS or OSI.^[@B27]^ Decreased WSS and increased OSI detected by vascular endothelium prohibit NO production and release atherogenic substances instead.^[@B28]--[@B32]^ It is therefore implicated that once an abnormal flow dynamics become dominant, they aggravate stiffness of the pulmonary artery and the vasoconstrictions of the peripheral pulmonary circulations, which cause abnormal flow dynamics, and then promote this vicious cycle. 3D cine PC MR is currently the only method that allows for direct and non-invasive measurement of these hemodynamic markers *in-vivo*.

Compared with 2D cine PC MR, 3D cine PC MR allows for 3D visual recognitions of the pulmonary artery, which is helpful in determining the measurement planes. Retrospective settings of the arbitrary planes can help avoid errors in flowmetry caused by inappropriately prescribed measurement planes that was often the case with 2D cine PC. In addition, with 3DFT data acquisition, SNR of the phase images is significantly improved. Moreover, 3D maps of the WSS and OSI color-coded on the pulmonary arteries can be generated quickly, and they allow more objective visual recognitions of spatial and temporal understandings of the abnormal flow dynamics taking place in the pulmonary arteries than mere numerical values.^[@B28]^

The limitations of this study are the relatively small number of patient population and the low temporal resolutions of the 3D cine PC MR for the cardiac phase, which may miss subtle temporal changes of the flow dynamics.

Conclusion
==========

In conclusion, our study suggested that sWSS, mWSS, and OSI of the pulmonary arterial trunk measured by 3D cine PC MR could be potential hemodynamic markers for the increased PAP in suspected secondary PAH patients.
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![The definitions of acceleration time (AT) and peak velocity (PV).](mrms-15-193-g1){#F1}

![Representative streamline analysis (**a**), WSS map (**b**), time course changes of the WSS values of the main pulmonary arterial wall and hemodynamic values (**c**) acquired in a 77-year-old male with non-PAH. Systolic streamlines of the pulmonary artery (**a**) show laminar, but no vortex flow. WSS in the time-averaged WSS-contour image of the pulmonary artery (**b**) is about 3 N/m^2^ or more. Spatially-averaged temporal WSS change in the pulmonary artery (**c**) show its peak at 166 ms from R wave (systole). Patients' data with non-PAH demonstrates a high value of BNP and normal PAP. The error bars represent the SD. AT, acceleration time; BNP, brain natriuretic peptide; PAH, pulmonary arterial hypertension; PAP, pulmonary arterial pressure; PV, peak velocity; RHC, right heart catheterization; s/d/m, systole/diastole/mean; sPAP, systolic pulmonary arterial pressure; UCG, ultrasound cardiography; WSS, wall shear stress.](mrms-15-193-g2){#F2}

![Representative streamline analysis (**a**), WSS map (**b**), time course changes of the WSS values of the main pulmonary arterial wall and hemodynamic values (**c**) acquired in a 75-year-old female with PAH. Streamlines of the pulmonary artery (**a**) show vortex flow (arrows) from the trunk to right pulmonary artery. WSS in the time-averaged WSS-contour image of the pulmonary artery (**b**) is about 1.5 N/m^2^ or less. Spatially-averaged temporal WSS changes in the pulmonary artery (**c**) show its peak at systole (244 ms from R wave), which is lower than non-PAH ([Fig. 2c](#F2){ref-type="fig"}). The error bars represent the standard deviation. Patient's data with PAH demonstrates that PAP is higher, BNP is lower, AT is higher and PA is lower as compared with non PAH patients. AT, acceleration time; BNP, brain natriuretic peptide; PAH, pulmonary arterial hypertension; PAP, pulmonary arterial pressure; PV, peak velocity; RHC, right heart catheterization; s/d/m, systole/diastole/mean; sPAP, systolic pulmonary arterial pressure; UCG, ultrasound cardiography; WSS, wall shear stress.](mrms-15-193-g3){#F3}

![Bland-Altman analysis plotted for intraoperator and interoperator agreements concerning the measurements of sWSS, mWSS, and OSI. The bias for each measurement was within the acceptable ranges. Intraoperator agreements on (**a**) sWSS for operator 1, (**b**) mWSS for operator 1, (**c**) OSI for operator 1, (**d**) sWSS for operator 2, (**e**) mWSS for operator 2, (**f**) OSI for operator 2; and interoperator agreements on (**g**) sWSS, (**h**) mWSS and (**i**) OSI.](mrms-15-193-g4){#F4}

###### 

Patients' demographics of non-PAH subgroups and PAH subgroups

  **non-PAH**                        **PAH**                                                                                                   
  ---------------------------------- ---------------------------------------------------- ------------------------------ --------------- ----- ---
  Diagnosis                          CVD-IP                                               2                              Diagnosis       IIP   1
  IIP                                1                                                    PAH                            1                     
  COPD                               4                                                    COPD                           2                     
  IP+COPD                            3                                                    Postoperation of lung cancer   1                     
  Sarcoidosis                        1                                                                                                         
  NTM                                1                                                                                                         
                                                                                                                                               
  BNP (pg/ml)                        78.4 ± 52.2\*                                        BNP (pg/ml)                    174.7 ± 186\*         
  A-aDO~2~ (mmHg)                    46.9 ± 20.7                                          A-aDO~2~ (mmHg)                35.3 ± 21.6           
  sPAP(UCG, mmHg)                    50.8 ± 19.3                                          sPAP (UCG, mmHg)               52.6 ± 16.6           
  mPAP (RHC, mmHg)                   18.3 ± 3.7\*                                         mPAP (RHC, mmHg)               33.6 ± 7.0\*          
  Data are presented as mean ± SD.   \*:statistically significant (*P* values \< 0.05).                                                        

A-aDO~2~, alveolar-arterial oxygen difference; BNP, brain natriuretic peptide; COPD, chronic obstructive pulmonary disease; CVD-IP, collagen vascular disease-interstitial pneumonia; F, female; IIP, idiopathic interstitial pneumonia; IP, interstitial pneumonia; M, male; NTM, nontuberculous mycobacteriosis; sPAP, systolic pulmonary arterial pressure; mPAP, mean pulmonary arterial pressure; PAH, pulmonary arterial hypertension; RHC, right heart catheterization; SD, standard deviation; UCG, ultrasound cardiography.

###### 

Differences of pulmonary arterial hemodynamic parameters between patients with and without pulmonary hypertension based on 3D cine phase contrast MR imaging data

                                    Total           Patients with PAH   Patients without PAH   *P* value
  --------------- ----------------- --------------- ------------------- ---------------------- -----------
  Parameter       No. of patients   17              5                   12                     --
  AT (msec)       0.189 ± 0.026     0.185 ± 0.020   0.192 ± 0.027       0.855                  
  PV (cm/sec)     53.02 ± 10.34     47.82 ± 8.33    55.19 ± 10.63       0.328                  
  sWSS (N/m^2^)   0.853 ± 0.257     0.594 ± 0.067   0.961 ± 0.590       0.001                  
  dWSS (N/m^2^)   0.257 ± 0.068     0.216 ± 0.072   0.275 ± 0.062       0.13                   
  mWSS (N/m^2^)   0.453 ± 0.125     0.365 ± 0.035   0.489 ± 0.132       0.027                  
  OSI             0.155 ± 0.056     0.214 ± 0.026   0.130 ± 0.046       0.001                  
  BVSA (mm^2^)    807.7 ± 226.8     1104.5 ± 62.1   684.1 ± 129.1       0.009                  

AT, acceleration time; BVSA, blood vessel section area; dWSS, diastolic wall shear stress; mWSS, mean wall shear stress; OSI, oscillatory shear index; PAH, pulmonary arterial hypertension; PV, peak velocity; sWSS, systolic wall shear stress.

###### 

Correlation coefficients between pulmonary artery hemodynamic parameters based on three-dimensional cine phase contrast magnetic resonance and pulmonary pressures based on right heart catheterization

  Parameter   mPAP                   sPAP                   dPAP
  ----------- ---------------------- ---------------------- ----------------------
  AT          −0.170 (*P* = 0.514)   −0.115 (*P* = 0.661)   −0.246 (*P* = 0.342)
  PV          −0.498 (*P* = 0.044)   −0.482 (*P* = 0.049)   −0.274 (*P* = 0.287)
  sWSS        −0.638 (*P* = 0.005)   −0.622 (*P* = 0.008)   −0.426 (*P* = 0.088)
  dWSS        −0.485 (*P* = 0.049)   −0.484 (*P* = 0.049)   −0.108 (*P* = 0.681)
  mWSS        −0.643 (*P* = 0.005)   −0.629 (*P* = 0.007)   −0.408 (*P* = 0.104)
  OSI         0.625 (*P* = 0.007)    0.594 (*P* = 0.012)    0.647 (*P* = 0.005)
  BVSA        0.523 (*P* = 0.031)    0.515 (*P* = 0.034)    0.659 (*P* = 0.004)

AT, acceleration time; BVSA, blood vessel section area; dWSS, diastolic wall shear stress; mWSS, mean wall shear stress; OSI, oscillatory shear index; PAH, pulmonary arterial hypertension; PV, peak velocity; sWSS, systolic wall shear stress.

###### 

Correlation coefficients between pulmonary artery hemodynamic parameters and pulmonary trunk blood vessel section area based on three-dimensional cine phase contrast magnetic resonance

  Parameter   BVSA
  ----------- -----------------------
  AT          --0.174 (*P* = 0.567)
  PV          --0.192 (*P* = 0.525)
  sWSS        --0.488 (*P* = 0.049)
  dWSS        --0.105 (*P* = 0.687)
  mWSS        --0.306 (*P* = 0.232)
  OSI         0.574 (*P* = 0.016)

AT, acceleration time; BVSA, blood vessel section area; dWSS, diastolic wall shear stress; mWSS, mean wall shear stress; OSI, oscillatory shear index; PV, peak velocity; sWSS, systolic wall shear stress.

###### 

The variations between two observers concerning the appearances of the abnormal flow patterns on pulmonary artery streamlines images

  Cardiac phase   Systole      Diastole                    
  --------------- ------------ ---------- --- --- ---- --- ---
  PAH             Observer 1   1          2   2   0    4   1
  Observer 2      1            3          1   0   3    2   
  non-PAH         Observer 1   10         2   0   3    9   0
  Observer 2      10           2          0   2   10   0   

Figures indicate the number of the patients. Grade 0: no abnormal flow (laminar flow in the systole and turbulent flow in the diastole); Grade 1, mild vortex and/or helical flow; Grade 2, severe vortex and/or helical flow; PAH, pulmonary arterial hypertension.

###### 

Intraoperator and interoperator correlation coefficients for measurements of wall shear stress and oscillatory shear index

  Parameter   Intraoperator 1        Intraoperator 2        Interoperator
  ----------- ---------------------- ---------------------- ----------------------
  sWSS        0.973 (*P* \< 0.001)   0.951 (*P* \< 0.001)   0.980 (*P* \< 0.001)
  dWSS        0.953 (*P* \< 0.001)   0.897 (*P* \< 0.001)   0.939 (*P* \< 0.001)
  mWSS        0.951 (*P* \< 0.001)   0.931 (*P* \< 0.001)   0.958 (*P* \< 0.001)
  OSI         0.941 (*P* \< 0.001)   0.924 (*P* \< 0.001)   0.939 (*P* \< 0.001)

dWSS, diastolic wall shear stress; mWSS, mean wall shear stress; OSI, oscillatory shear index; sWSS, systolic wall shear stress.
